Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nemaska Lithium Inc NMKEF

Nemaska Lithium Inc is a Canada based lithium company. It is engaged in exploring and evaluating lithium properties and processing of spodumene into lithium compounds in Quebec, Canada. The company supplies lithium hydroxide and lithium carbonate to the lithium battery industry used in electric vehicles, cell phones, tablets, and other consumer products.


GREY:NMKEF - Post by User

Bullboard Posts
Comment by HabberPleaseon May 29, 2018 9:25am
155 Views
Post# 28092618

RE:How many common shares are being issued?

RE:How many common shares are being issued?
Here's a pro forma capitalization from p.19 of the latest Prospectus available on Sedar website…

CONSOLIDATED CAPITALIZATION
Since March 31, 2018, there have been no material changes in the Corporation’s share or loan capital, other than the issuance of an aggregate of 375,000 Common Shares of the Corporation following the  exercise  of  an  aggregate  of  375,000 options, for an aggregate cash consideration of $187,500 and the issuance of 88,460,446 Subscription Receipts pursuant to the SoftBank Private Placement (the “Capital Transactions”).
 
The following table represents the Corporation’s share capital as at March 31, 2018, on a pro forma basis after giving effect to the Offering (assuming no exercise of the Over-Allotment Option), the Contemporaneous Private Placement, and the Capital Transactions and on a pro forma basis after giving effect to Project Financing Package and the Capital Transaction. It should be read in conjunction with the Interim Financial Statements and the Interim MD&A, including the notes thereto, which are incorporated by reference herein.
 
    As at March 31, 2018   After Giving Effect to Offering, the Contemporaneous Private Placement and the Capital Transactions(6)   After Giving Effect to
the Project Financing Package and the Capital Transactions(6)
Loan Capital and Stream Facility(7):           $650,000,000
             
Share Capital:            
             
Common Shares and Warrants   $208,156,732 (401,643,577 Common Shares and 29,274,823 warrants)   $662,120,725
(845,747,588 Common Shares)(1)
(29,274,823 warrants)(2)
  $662,120,725
(845,747,588 Common Shares)(1)
(29,274,823 warrants)(2)
             
Options   (16,324,484 options)   (15,949,484 options)(3)   (15,949,484 options)(3)
             
Broker Options and Broker Warrants   (1,550,812 broker options and broker warrants(4)(5))   (1,550,812 broker options and broker warrants(4)(5))   (1,550,812 broker options and broker warrants(4)(5))
             
 
(1)           If the Over-Allotment Option is exercised in full, 887,747,588 Common Shares (assuming no exercise of the SoftBank Adjustment Right).

(2)           Total dollar value that the Corporation would receive, assuming all the warrants outstanding as of the date this Prospectus Supplement are exercised before their expiry dates, amounts to $43,912,234.

(3)           Total dollar value that the Corporation would receive, assuming all the options outstanding as of the date this Prospectus Supplement are exercised before their expiry dates, amounts to $12,194,734.

(4)           The broker options were issued pursuant to the July 2016 prospectus offering. Each broker option is exercisable, at a price of $1.15 per broker option, for one Common Share and one-half of one common share purchase warrant (each whole common share purchase warrant a “broker warrant”). The total dollar value that the Corporation would receive, assuming all of the broker options outstanding as of the date of this Prospectus Supplement (including all of the underlying broker warrants) are exercised before their expiry dates, amounts to $1,397,427. As of the  date  of  this  Prospectus  Supplement,  there  are  735,488  broker  options  left  to  be  exercised. The underlying broker warrants are exercisable at a price of $1.50 per common share.

(5)           The broker warrants were issued following the exercise of broker options issued pursuant to the July 2016 prospectus offering. The total dollar value that the Corporation would receive, assuming all of the 447,580 broker warrants outstanding as of the date of this Prospectus Supplement are exercised before their expiry dates, amounts to $671,370. The broker warrants are exercisable at a price of $1.50 per common share.

(6)           Assuming the conversion of 83,729,011 Subscription Receipts into 83,729,011 Common Shares for an aggregate proceed of $93,776,493 released to the Corporation.

(7)           Loan capital comprises the issuance of USD$350 million ($455 million based on exchange rate of US$1.00/CAD$1.30) pursuant to the Bond Offering and US$150 million ($195 million based on exchange rate of US$1.00/CAD$1.30) pursuant to the Stream Facility. Deferred financing costs will be presented against the financial liabilities in the consolidated financial position of the Corporation.



Bottoms wrote: Anyone have the before and after number of common shares? I'm trying to figure out how many are being issued / how long it will take to have them out.. This will turn out to be a great story. So much promise here in one of the safest environments in the world. Bottoms


Bullboard Posts